Navigation Links
Cornerstone Therapeutics Announces New Board of Directors
Date:11/5/2008

CARY, N.C., Nov. 5 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTXD)*, a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders, today announced that, pursuant to the terms of the recently completed merger between Cornerstone BioPharma Holdings, Inc. and Critical Therapeutics, Inc., Craig A. Collard, 42, president and chief executive officer and a member of Cornerstone BioPharma's board of directors, has been appointed chairman of the board of the newly combined company, Cornerstone Therapeutics, in addition to his position as president and chief executive officer of the combined company. Also, Alastair McEwan, 52, chairman of the board of Cornerstone BioPharma, has been appointed to the board of directors of Cornerstone Therapeutics.

Concurrently, Cornerstone Therapeutics also appointed three independent directors to its board: Christopher Codeanne, 40, Michael Enright, 46, and Michael Heffernan, 43.

"I look forward to working closely with my fellow board members to create a leading specialty pharmaceutical company," said Mr. Collard. "Their diverse financial management and pharmaceutical industry backgrounds will provide us with valuable insight and experience as we continue growing our business."

Mr. Codeanne has served since April 2008 as Chief Operating Officer and Chief Financial Officer of Oncology Development Partners, LLC (d/b/a Oncopartners), a specialized international oncology contract research organization. He served as the Chief Financial Officer of Averion International Corp., a publicly-traded international contract research organization, from December 2006 through April 2008. Prior to Averion, from 2002 through July 2006, Mr. Codeanne was the Chief Financial Officer of SCIREX Corporation LLC, now Premier Research Group plc, an international, full-service clinical research organization. From 1999 to 2002, he was Director of Fina
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
2. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
3. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
4. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
5. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
6. Arno Therapeutics Appoints William F. Hamilton to Board of Directors
7. Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program
8. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
9. Preliminary Clinical Data Presented at the 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrate Superior Profile of S*BIOs Novel Anti-Cancer Drug SB939
10. Synvista Therapeutics Appoints William Federici to its Board of Directors
11. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...SHINGTON, Nov. 9 The Churchill C...Award For Leadership to J.W. "Bill" Marriott for h...ugh progressive free market practices and fosterin... Mr. Marriott will receive his award at a ceremony...ton D.C. Four Seasons Hotel. ,, "This is a tes...
(Date:11/9/2009)...elped men and women almost equally, study finds, ...he widely used clot-dissolving drug Plavix (clopid... analysis of major clinical trials has found. ,...in treating both men and women with this very impo...of cardiovascular thrombosis at New York Universit...
(Date:11/9/2009)...on of plans finds differences in mood despite simi...thDay News) -- Both a high-fat, low-carbohydrate d...at, high-carb diet appear to help people lose poun...d? Only the low-fat diets will result in long-term...Nov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)... Tomorrow may be too late when it...tion, according to TOPS Club, Inc. (Take Off Pound...anization. , (Vocus) Nove...omes to preventing or improving a diabetes conditi...Sensibly), the nonprofit weight-loss support organ...
(Date:11/9/2009)...BANON, Tenn., Nov. 9 Health Connec...nced it will host their inaugural Hospital O.R. an... at the Marriott Renaissance Hotel in Nashville, T...re than 100 hospital operating room directors and ...alth systems in the country. Some of the confirmed...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
...al shows novel compound blocks enzyme triggering c...4 (HealthDay News) -- A drug designed to lessen mu... safety tests in humans. , The drug, known as KAI-...ervention (PCI). PCI is a set of procedures includ...
...reading of screening mammograms with computer-aide...ading and yields a higher sensitivity than the fir...o a study conducted by researchers at Charlotte Ra...onsisted of the mammogram being first read by sub-...
...echnique that combines bone marrow removal and inj...of new bone at targeted locations in the body, it ... in Tissue Engineering. , "This could radically c...gns Vignery , associate professor of orthopedics ...
...O(TM) Beverage Provides Refreshing Taste with Bene... International today,launches HIRO(TM) Super Fruit...its popular HIRO(TM) ready-to-drink noni-based bev...pe., HIRO Super Fruits Sparkling Black Currant is...
..., Feb. 14 Today, the Centers for,Disease Control ...sting,performed on occupied FEMA travel trailers. ... testified before the Committee on Homeland,Securi...associated with prolonged formaldehyde exposure ca...
...aeli scientist, Dr. Siegal Sadetzki, has found a l...f tumors. , Dr. Sadetzki, a physician, epidemiol...ed the results of a study recently in the American...rs of the salivary gland. , Those who used a cel...
Other Medicine News:Health News:Drug Cuts Muscle Damage After Heart Attack 2Health News:Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive 2Health News:Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant 2Health News:Thompson Demands Solution to Formaldehyde Trailer Crisis 2Health News:Cell phone-cancer link found by Tel Aviv University scientist 2
(Date:11/9/2009)...ION, N.J., Nov. 9 Unwavering from ...s, but recognizing today,s economic climate, Lutro...thetic laser systems, introduces the MOSAIC CO2, a...er $50,000. ,, The MOSAIC CO2 offers many of t...logy including scanning and stamping operation mod...
(Date:11/9/2009)... Nov. 9 Decision Resources, one of...or pharmaceutical and healthcare issues, finds tha... 2 (HER2) targeting therapies -- which include Roc...ayaku,s Tykerb/Tyverb -- were the highest-selling ...ptake of Herceptin and Tykerb/Tyverb and the expec...
(Date:11/9/2009)... Nov. 9 ARmark Authentication Tech...an alliance in the development and introduction of...ion technology that incorporates microscopic cover...ngs of solid oral dosage forms (SODFs) to prevent ...lusive rights to market ARmark,s micro-tags for ta...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Research breakthrough will lead to more accurate weather forecasts 13460 1Research breakthrough will lead to more accurate weather forecasts 13460 2Mental Activity Seems to Keep the Brain Vital 54005 1Mental Activity Seems to Keep the Brain Vital 54005 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 1The Sloane Clinic pioneers Ultherapy in Singapore 54003 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 3
...ntinues to anticipate CHMP opinion in the third qu...mission decision in the fourth ...Pharma, Inc.,(Nasdaq: IDMI ) today announced that...requested additional data analyses from the Phase ...o complete the additional data,analyses, respond t...
...ss., July 1 Echo Therapeutics,Inc. (OTC Bulletin ... a,clinical study of its Symphony(TM) Transdermal ... in patients with Type 1 and Type 2,diabetes. The ...ts of the,study in the third quarter of 2008. Echo...ts Prelude(TM) SkinPrep System, which incorporates...
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 2Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 3
ALLEGRO Analyzer
RESTASIS®
LADARWave® Aberrometer
ZYMAR™ 2.5 mL
Medicine Products: